LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis.

    Yamada, Takayuki / Wakabayashi, Mako / Yamaji, Takahiro / Chopra, Nitin / Mikami, Takahisa / Miyashita, Hirotaka / Miyashita, Satoshi

    Clinica chimica acta; international journal of clinical chemistry

    2020  Volume 509, Page(s) 235–243

    Abstract: ... In patients with COVID-19, fever, leukocytosis, and an elevated CRP were associated with severe outcomes ... the association between severe COVID-19 and a change in white blood cell (WBC) count, an elevation of C-reactive ... Background: Since December 2019, coronavirus 2019 (COVID-19) has spread worldwide. Identifying ...

    Abstract Background: Since December 2019, coronavirus 2019 (COVID-19) has spread worldwide. Identifying poor prognostic factors is helpful for risk stratification. In this meta-analysis, we investigated the association between severe COVID-19 and a change in white blood cell (WBC) count, an elevation of C-reactive protein (CRP), and fever. Moreover, we aimed to evaluate the diagnostic accuracy of leukocytosis and an elevation of CRP.
    Methods: We performed a systematic search of PubMed, EMBASE, Scopus, and the Cochrane Library through April 20th, 2020. The odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. A sensitivity analysis was conducted according to the study size (>200 or <200) and median age (>55 or <55). Meta-regression analyses were conducted to examine possible sources of heterogeneity. We calculated the diagnostic accuracy of leukocytosis and CRP.
    Results: Eighteen studies with 3278 patients were selected. Fever, leukocytosis, and elevated CRP were associated with poor outcomes (OR (95% CI) 1.63 (1.06-2.51), 4.51 (2.53-8.04), and 11.97 (4.97-28.8), respectively). Leukopenia was associated with a better prognosis (OR 0.56, 95% CI 0.40-0.78). Sensitivity analyses showed similar tendencies. Meta-regression analysis for leukocytosis indicated that age, dyspnea, and hypertension contributed to heterogeneity. The pooled area under the leukocytosis and CRP curves were 0.70 (0.64-0.76) and 0.89 (0.80-0.99), respectively.
    Conclusion: In patients with COVID-19, fever, leukocytosis, and an elevated CRP were associated with severe outcomes. Leukocytosis and CRP on arrival may predict poor outcomes.
    MeSH term(s) Betacoronavirus ; Biomarkers/blood ; C-Reactive Protein/metabolism ; COVID-19 ; Coronavirus Infections/blood ; Coronavirus Infections/diagnosis ; Coronavirus Infections/epidemiology ; Humans ; Leukocytosis/blood ; Leukocytosis/diagnosis ; Leukocytosis/epidemiology ; Leukopenia/blood ; Leukopenia/diagnosis ; Leukopenia/epidemiology ; Pandemics ; Pneumonia, Viral/blood ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/epidemiology ; Prognosis ; Retrospective Studies ; SARS-CoV-2
    Chemical Substances Biomarkers ; C-Reactive Protein (9007-41-4)
    Keywords covid19
    Language English
    Publishing date 2020-06-10
    Publishing country Netherlands
    Document type Journal Article ; Meta-Analysis ; Systematic Review
    ZDB-ID 80228-1
    ISSN 1873-3492 ; 0009-8981
    ISSN (online) 1873-3492
    ISSN 0009-8981
    DOI 10.1016/j.cca.2020.06.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis

    Yamada, Takayuki / Wakabayashi, Mako / Yamaji, Takahiro / Chopra, Nitin / Mikami, Takahisa / Miyashita, Hirotaka / Miyashita, Satoshi

    Clin Chim Acta

    Abstract: ... between severe COVID-19 and a change in white blood cell (WBC) count, an elevation of C-reactive protein ... with COVID-19, fever, leukocytosis, and an elevated CRP were associated with severe outcomes. Leukocytosis ... BACKGROUND: Since December 2019, coronavirus 2019 (COVID-19) has spread worldwide. Identifying poor ...

    Abstract BACKGROUND: Since December 2019, coronavirus 2019 (COVID-19) has spread worldwide. Identifying poor prognostic factors is helpful for risk stratification. In this meta-analysis, we investigated the association between severe COVID-19 and a change in white blood cell (WBC) count, an elevation of C-reactive protein (CRP), and fever. Moreover, we aimed to evaluate the diagnostic accuracy of leukocytosis and an elevation of CRP. METHODS: We performed a systematic search of PubMed, EMBASE, Scopus, and the Cochrane Library through April 20th, 2020. The odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. A sensitivity analysis was conducted according to the study size (>200 or <200) and median age (>55 or <55). Meta-regression analyses were conducted to examine possible sources of heterogeneity. We calculated the diagnostic accuracy of leukocytosis and CRP. RESULTS: Eighteen studies with 3278 patients were selected. Fever, leukocytosis, and elevated CRP were associated with poor outcomes (OR (95% CI) 1.63 (1.06-2.51), 4.51 (2.53-8.04), and 11.97 (4.97-28.8), respectively). Leukopenia was associated with a better prognosis (OR 0.56, 95% CI 0.40-0.78). Sensitivity analyses showed similar tendencies. Meta-regression analysis for leukocytosis indicated that age, dyspnea, and hypertension contributed to heterogeneity. The pooled area under the leukocytosis and CRP curves were 0.70 (0.64-0.76) and 0.89 (0.80-0.99), respectively. CONCLUSION: In patients with COVID-19, fever, leukocytosis, and an elevated CRP were associated with severe outcomes. Leukocytosis and CRP on arrival may predict poor outcomes.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #32533986
    Database COVID19

    Kategorien

  3. Article ; Online: Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19)

    Yamada, Takayuki / Wakabayashi, Mako / Yamaji, Takahiro / Chopra, Nitin / Mikami, Takahisa / Miyashita, Hirotaka / Miyashita, Satoshi

    Clinica Chimica Acta

    A systematic review and meta-analysis

    2020  Volume 509, Page(s) 235–243

    Keywords Clinical Biochemistry ; Biochemistry ; Biochemistry, medical ; General Medicine ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 80228-1
    ISSN 1873-3492 ; 0009-8981
    ISSN (online) 1873-3492
    ISSN 0009-8981
    DOI 10.1016/j.cca.2020.06.008
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top